Summary
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.
History
SeaSpine was founded in January 2007 and is headquartered in Carlsbad, California. They entered the orthobiologics market with the launch of the Mariner family of spinal implants in 2013. In 2015, SeaSpine completed the acquisition of General Medical Merit Medical, a leading supplier of spine and orthopedic implants in the United States. This strategic acquisition has enabled SeaSpine to expand its spine portfolio and presence in both the U.S. and international markets.
Mission
At SeaSpine, we design, develop and manufacture the highest-quality spine products to provide surgeons with effective solutions to improve the quality of life for patients.
Vision
Our vision is to be recognized as the leader in spine surgery and orthobiologics by providing innovative products, services and education that deliver value to our customers and partners.
Key Team
Dr. Frank Vizesi (Chief Scientific Officer)
Carrie Mendivil (Head of Investor Relations)
Mr. Patrick L. Keran J.D. (Sr. VP, Gen. Counsel & Sec.)
Mr. John J. Winge (VP of Sales)
Ms. Hollis Winkler (Sr. VP of HR)
Mr. Tyler P. Lipschultz (Sr. VP of Orthobiologics & Bus. Devel.)
Mr. Dennis L. Cirino (Sr. VP of Global Spinal Systems)
Recognition and Awards
SeaSpine has been recognised for innovation in its products and technology, having been awarded ‘Best in Class’ for its three titanium coated implants at the 2015 Annual European Congress of Spine Orthopaedics . The company also has two FDA 510 clearances for their Mariner and Vista implants.
References